WHY PAXLOVID REMAINS YOUR GO-TO MEDICINE AGAINST COVID

 

Paxlovid the antiviral medication developed by Pfizer remains a very important tool in our fight against COVID-19. This medication is important in saving the lives of patients for several reasons.

 

First, Paxlovid is an effective oral medication against COVID. This means it can easily be self administered by patients if guided by knowledgeable healthcare professionals on the right use of the medication. The medication has shown to reduce hospitalization and death by 89.1% and 88.9%, respectively.

 

Secondly, the medicine has a short duration of treatment. A five days course has proven to be effective in preventing the virus from replicating. This reduces viral load and prevents complications due to the corona virus infection.

 

In addition, it can be taken by almost everyone and is readily accessible. The most serious drug-drug interactions associated with the medication use are interactions with rivaroxaban and salmeterol, respectively.

 

Lastly, it might just be a vital tool in managing Long COVID. Some experts assume Long COVID might be as a result of persistence of the virus in the body of its host. This means if you stop the virus from replicating, you’re going to get less amount of viral particles in the body of the patient.

 

For more information on how to use and access Paxlovid contact here.  

COURT DISMISSES APPLICATION AIMED AT PREVENTING PHARMACISTS FROM PRESCRIBING ANTIRETROVIRAL MEDICINES IN SOUTH AFRICA

 

A Pretoria High Court dismisses application brought by a physician association (IPA Foundation) that aimed at preventing pharmacists from managing and prescribing medicines to patients with HIV and tuberculosis. 

 

The approval means Patients Living With HIV (PLWH) will have increased access to their medicines at pharmacies that are taking part in the Pharmacy Initiated Management of Antiretroviral Treatment (PIMART) program.

 

”The untapped value of pharmacists in fighting HIV was also emphasized by the efficient role pharmacies played in meeting healthcare needs and providing healthcare services during the COVID-19 pandemic,” said the Pretoria High Court Judge, Elmarie Van Der Schyff.

 

According to UNAIDS, an estimated 7 million South Africans children and adults are living with HIV.

 

For more information on this update visit here

PFIZER GETS APPROVAL FOR RSV VACCINE

 

Pfizer gets the Food and Drug Administration (FDA) approval for her vaccine against the Respiratory Syncytial Virus (RSV). The vaccine will help protect infants, pregnant women, and individuals 60 years and above from the harmful effects of RSV.

 

RSV is a very infectious virus that affects the lungs and can lead to life threatening medical conditions like pneumonia, bronchiolitis, and congestive cardiac failure, if left untreated. Globally, every year, RSV is estimated to cause 33 million cases of infection and an estimated 199,000 deaths of children under five years.

 

‘This is a significant milestone in public health, its the first and only maternal immunization available to help pregnant women protect their infants from respiratory illnesses cause by the virus,’ says the Chief Executive Officer of Pfizer, Albert Bourla.

 

For more information on this visit here. To learn more about the vaccine visit here. You can learn about our previous updates by visiting here.